Fig. 4: Repeated-dose toxicity study. | Experimental & Molecular Medicine

Fig. 4: Repeated-dose toxicity study.

From: Therapeutic potential of a phospholipase D1 inhibitory peptide fused with a cell-penetrating peptide as a novel anti-asthmatic drug in a Der f 2-induced airway inflammation model

Fig. 4

a Schedule for repeated-dose toxicity test of TAT-TVTSP. b The organs were weighed, and the values were expressed as the organ weight/body weight and presented as the means ± SD of 10 mice per group. Differences were assessed by one-way ANOVA. *P < 0.05 compared with the brain weight of the untreated control. c Fixed organ samples were dehydrated, paraffinized, and embedded. Sections of 4 µm were stained with H&E and observed under a microscope. Scale bar, 100 µm

Back to article page